DX Deals

Global Collaboration Seeks to Develop Game-Changing Handheld COVID-19 Breathalyzer Test

A handheld, easy-to-use breathalyzer device capable of accurately detecting COVID-19 at the point of care would represent a breakthrough in the effort to contain the spread of the virus. That vision … [Read more...]

M&A Report

Hologic Turns COVID-19 Testing Cash into Strategic Acquisitions in Core Women’s Health Space

M&A deal making in the diagnostics marketing is off to a very fast start in 2021. The biggest deal announced in January was PerkinElmer’s bid to expand its infectious disease testing capabilities … [Read more...]

Industry Buzz

Myriad Genetics Puts Its Autoimmune Division Up for Sale

What a difference a pandemic makes! Last year at this time, molecular genetic testing was a fairly soft market. But the unprecedented and unexpected demand for COVID-19 diagnostics has lifted the … [Read more...]

DX Deals

Siemens, California Health Network and Biopharm Research Company Partner for Enhanced Liver Fibrosis Testing

Although COVID-19 remains the driving force, non-pandemic-related strategic deal making continues. Among the most impactful deals announced in December is the partnership among Renown Institute for … [Read more...]

M&A Review

2020 M&A Year in Review: Deal Making Was Low in Volume but High in Impact

Not surprisingly, the COVID-19 pandemic exerted a pronounced chilling effect on M&A activity in the diagnostic space as both buyers and sellers adopted a wait-and-see attitude. But the decline in … [Read more...]

M&A Report

CompuGroup Medical Makes Major LIS Play by Acquiring Schuyler House

It seems fitting that the pandemic year of 2020 should end not with a bang but a whimper. December was the slowest month in M&A deal making of not only this year but many years in recent memory … [Read more...]

M&A Report

Look for Health Care Mergers and Acquisitions to Resurge in 2021

Last year at this time, the expectation was that 2020 would be an unusually active year for health care mergers and acquisitions. But the pandemic forced deal makers to shelve their plans and await … [Read more...]

DX Earnings Report

Q3 Creates the Perfect Storm of Sustained COVID-19 Tailwinds and Diminishing Headwinds

July through September 2020 was a remarkable quarter for most diagnostics firms. In fact, it was the closest thing to a perfect storm for earnings. Pandemic tailwinds drove massive revenues for firms … [Read more...]

DX Deals

Fitness Wearables Makers Look to Apply Technology for Consumer-Based Diagnostics

Could the Fitbit, smartwatch and other wearable devices be a key to resolving the current COVID-19 testing and other diagnostic challenges? Momentum for applying wearables health and wellness … [Read more...]

M&A Report

Exact Sciences Makes a Bold Double Play to Bolster Its Early Cancer Detection Capabilities

Although volume was light, October was a robust month for M&A deal making in terms of impact, especially in the cancer diagnostics space. The month started with the announcement of Invitae’s … [Read more...]


(-00000g2)